KAMAL HAMED
CIK 1946366 · Chief Medical Officer · last filed 2024-02-05
KAMAL HAMED is a Chief Medical Officer who has filed 5 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for SPRO, was dated Feb 5, 2024. Across all open-market trades the lifetime net is −$88.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.73M
1
5
-$88.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRO | Chief Medical Officer | 816,192 | $2.12 | $1.73M | -$88.6K | 5 | 2024-02-05 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-05 | SPRO | Mixed | +211,656 | -$38.5K | EDGAR |
| 2023-09-15 | SPRO | Sell (S) | −39,496 | -$50.2K | EDGAR |
| 2023-06-14 | SPRO | Grant (A) | +140,000 | $0 | EDGAR |
| 2023-02-03 | SPRO | Grant (A) | +265,957 | $0 | EDGAR |
| 2022-09-14 | SPRO | Grant (A) | +210,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.